Capecitabine
- Product NDC
- 72205-007
- 11-digit product format
- 722050007
- Labeler code
- 72205
- Product ID
- 72205-007_136d5048-1342-4a83-b6ce-db9f8933741c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Capecitabine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Novadoz Pharmaceuticals LLC
- Application
- ANDA209365
- Marketing category
- ANDA
- Marketing start
- 2018-07-21
- Substance
- CAPECITABINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Capecitabine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CAPECITABINE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6804DJ8Z9U |
| Rxcui | 200327, 200328 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72205-007-92 | Capecitabine | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72205-007 | CAPECITABINE TABLET, FILM COATED [NOVADOZ PHARMACEUTICALS LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240820_29885ada-b743-419c-8f15-edd4247c76ca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72205-007-92 | 72205000792 | 120 TABLET, FILM COATED in 1 BOTTLE (72205-007-92) | 2018-07-21 | 0000-00-00 | No | No | Current |